Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Abstract: With the development of vehicular ad-hoc networks (VANETs), several data security challenges are revealed, such as data hijacking and interception. Although vehicles are authorized, ...